New Peptides for the Treatment of Multiple Sclerosis

Norton, Raymond (Primary Chief Investigator (PCI))

Medicinal Chemistry

Project: Research

Status	Finished
Effective start/end date	1/09/11 → 31/05/16

Funding

NIH - National Institutes of Health (United States of America): A$315,623.00

5 Article

N-terminally extended analogues of the K+ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3
Chang, S. C., Huq, R., Chhabra, S., Beeton, C., Pennington, M. W., Smith, B. J. & Norton, R. S., 2015, In: The FEBS Journal. 282, 12, p. 2247-2259 13 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

30 Citations (Scopus)
A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases
Rashid, H., Huq, R., Tanner, M. R., Chhabra, S., Khoo, K. K., Estrada, R., Dhawan, V., Chauhan, S., Pennington, M. W., Beeton, C., Kuyucak, S. & Norton, R. S., 2014, In: Scientific Reports. 4, 4509, p. 1 - 9 9 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

77 Citations (Scopus)
Computational approaches for designing potent and selective analogs of peptide toxins as novel therapeutics
Kuyucak, S. & Norton, R. S., 2014, In: Future Medicinal Chemistry. 6, 15, p. 1645 - 1658 14 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

27 Citations (Scopus)